West Pharmaceutical Services Announces Third Quarter 20...(ority interests 0...),Health

Income from consolidated operations 63.7 (0.2) 63.5

Equity in net income of affiliated

companies 1.5 - 1.5

Income from continuing operations $65.2 $(0.2) $65.0

Net income per diluted share:

Continuing operations $1.86 $- $1.86

Please refer to the "Notes to Non-GAAP financial measures" for more information. Non-GAAP measures are intended to explain or aid in the use of,

not as a substitute for, the related GAAP financial measure.

WEST PHARMACEUTICAL SERVICES

NON-GAAP MEASURES (UNAUDITED)

NINE MONTHS ENDED SEPTEMBER 30, 2006

(in millions, except per share data)

As

Reported Non-GAAP

September Extinguish- September

30, ment Tax 30,

2006 of Debt Settlement 2006

Operating profit $80.0 $ - $ - $80.0

Loss on debt extinguishment 5.9 (5.9) - -

Interest expense, net 8.5 - 0.3 8.8

Income before income taxes and

minority interests 65.6 5.9 (0.3) 71.2

Provision for income taxes 19.4 1.8 0.4 21.6

Minority interests 0.3 - - 0.3

Income from consolidated

operations 45.9 4.1 (0.7) 49.3

Equity in net income of

affiliated companies 0.9 -
'/>"/>